This content is restricted.
Brief
"On 30 November 2024, the European Medicines Agency (EMA) advises marketing authorisation holders to submit type IA and type IAIN variations for 2024. Submissions for type IB variations or groupings of type IBs and type IAs can also be made by this deadline, with a start of procedure in 2024. For queries related to these procedures, companies can raise a ticket via the EMA Service Desk or email the dedicated mailbox: nfr@ema.europa.eu."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
